Voyager Therapeutics's total assets for Q1 2025 were $353.24M, a decrease of -10.13% from the previous quarter. VYGR total liabilities were $80.54M for the fiscal quarter, a -13.67% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.